Supernus Pharmaceuticals, Inc.

... ...
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. 0.55%26.8314.1%$157.87m
HZNPHorizon Therapeutics Plc -0.27%77.235.6%$151.68m
ACRSAclaris Therapeutics, Inc. 1.27%18.275.3%$139.68m
CTLTCatalent, Inc. -1.13%116.952.1%$102.69m
BHCBausch Health Cos., Inc. 0.73%26.880.0%$100.93m
JAZZJazz Pharmaceuticals Plc 0.07%165.892.4%$86.49m
ACSTAcasti Pharma, Inc. -6.39%0.780.2%$81.94m
ISRIsoRay, Inc. -3.73%2.322.5%$62.17m
UTHRUnited Therapeutics Corp. -0.91%165.6214.1%$61.46m
AMRNAmarin Corp. Plc 2.22%6.451.5%$51.55m
GWPHGW Pharmaceuticals Plc -0.31%137.996.1%$50.54m
PRGOPerrigo Co. Plc -0.93%43.026.8%$49.97m
ARGXargenx SE -1.26%311.330.0%$48.52m
TNXPTonix Pharmaceuticals Holding Corp. 7.13%1.050.2%$45.14m
SAGESAGE Therapeutics, Inc. -5.71%87.167.6%$42.70m

Company Profile

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.